Raisins in human health: A review

In the last years, the scientific research in the field of non-alcoholic grape products has increased significantly. Raisins are often evaluated negatively from the nutritional point of view, mainly for their high sugar content. On the other hand, some in vitroand in vivostudies have suggested that...

Full description

Saved in:
Bibliographic Details
Published inBIO web of conferences Vol. 7; p. 4005
Main Authors Restani, Patrizia, Frigerio, Gianfranco, Colombo, Francesca, de Sousa, Luis Peres, Altindişli, Ahmet, Pastor, Raul Francisco, Lorenzo, Chiara Di
Format Journal Article Conference Proceeding
LanguageEnglish
Published Les Ulis EDP Sciences 2016
Subjects
Online AccessGet full text
ISSN2117-4458
2273-1709
2117-4458
DOI10.1051/bioconf/20160704005

Cover

More Information
Summary:In the last years, the scientific research in the field of non-alcoholic grape products has increased significantly. Raisins are often evaluated negatively from the nutritional point of view, mainly for their high sugar content. On the other hand, some in vitroand in vivostudies have suggested that raisins could have healthy effects due to their positive phytochemical profile. The aim of this work was the collection of scientific studies performed in humans to assess critically the health-promoting effects of raisins, as a part of the normal/Mediterranean diet. In most cases, the beneficial effects of raisins have been assessed in intervention studies focused on cardiovascular area, diabetes and oral health, where a decrease in postprandial glycemia and insulinemia both in diabetic and healthy subjects has been observed. The positive effects were generally evident after a short-term consumption of about 70 g/die of raisins in comparison to a similar quantity of snacks or glucose solution. Surprisingly, some positive findings were shown in oral health. On these bases several findings support the suitability of raisins as a source of healthy compounds for human diet, but limits in the data published till now clearly support the need of new specifically designed trials.
Bibliography:ObjectType-Conference Proceeding-1
SourceType-Conference Papers & Proceedings-1
content type line 21
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2117-4458
2273-1709
2117-4458
DOI:10.1051/bioconf/20160704005